Global Blood Vessels Embolic Agents Production, Demand and Key Producers, 2022-2028
Playing a more vital role in the field of medicine than ever before, embolotherapy is a type of endovascular treatment that aims to occlude abnormal blood vessels in order to control bleeding, close fistulae or arteriovenous malformations, devascularise organs, reduce tumours and much more. This report focus on Blood Vessels Embolic Agents market.
This report studies the global Blood Vessels Embolic Agents demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Blood Vessels Embolic Agents, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Blood Vessels Embolic Agents that contribute to its increasing demand across many markets.
The global Blood Vessels Embolic Agents market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Blood Vessels Embolic Agents total market, 2017-2028, (USD Million)
Global Blood Vessels Embolic Agents total market by region & country, CAGR, 2017-2028, (USD Million)
U.S. VS China: Blood Vessels Embolic Agents total market, key domestic companies and share, (USD Million)
Global Blood Vessels Embolic Agents revenue by player and market share 2017-2022, (USD Million)
Global Blood Vessels Embolic Agents total market by Type, CAGR, 2017-2028, (USD Million)
Global Blood Vessels Embolic Agents total market by Application, CAGR, 2017-2028, (USD Million)
This reports profiles major players in the global Blood Vessels Embolic Agents market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Boston Scientific Corporation, Cook Medical LLC, Johnson & Johnson, Medtronic, Acandis GmbH, SSEM Mthembu Medical (Pty) Ltd, Balt USA LLC and Stryker, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Blood Vessels Embolic Agents market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Blood Vessels Embolic Agents Market, By Region:
1. How big is the global Blood Vessels Embolic Agents market?
2. What is the demand of the global Blood Vessels Embolic Agents market?
3. What is the year over year growth of the global Blood Vessels Embolic Agents market?
4. What is the total value of the global Blood Vessels Embolic Agents market?
5. Who are the major players in the global Blood Vessels Embolic Agents market?
6. What are the growth factors driving the market demand?
This report studies the global Blood Vessels Embolic Agents demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Blood Vessels Embolic Agents, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Blood Vessels Embolic Agents that contribute to its increasing demand across many markets.
The global Blood Vessels Embolic Agents market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Blood Vessels Embolic Agents total market, 2017-2028, (USD Million)
Global Blood Vessels Embolic Agents total market by region & country, CAGR, 2017-2028, (USD Million)
U.S. VS China: Blood Vessels Embolic Agents total market, key domestic companies and share, (USD Million)
Global Blood Vessels Embolic Agents revenue by player and market share 2017-2022, (USD Million)
Global Blood Vessels Embolic Agents total market by Type, CAGR, 2017-2028, (USD Million)
Global Blood Vessels Embolic Agents total market by Application, CAGR, 2017-2028, (USD Million)
This reports profiles major players in the global Blood Vessels Embolic Agents market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Boston Scientific Corporation, Cook Medical LLC, Johnson & Johnson, Medtronic, Acandis GmbH, SSEM Mthembu Medical (Pty) Ltd, Balt USA LLC and Stryker, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Blood Vessels Embolic Agents market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Blood Vessels Embolic Agents Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Microsphere
- Liquid Embolics Agents
- Embolic Coils
- Embolic Plug Systems
- Detachable Balloons
- Others
- Hospital & Clinic
- Ambulatory Surgical Center
- Others
- Abbott
- Boston Scientific Corporation
- Cook Medical LLC
- Johnson & Johnson
- Medtronic
- Acandis GmbH
- SSEM Mthembu Medical (Pty) Ltd
- Balt USA LLC
- Stryker
- Guerbet LLC
- Terumo Corporation
- Penumbra
- Grandpharma (Sirtex)
- Merit Medical
- Siemens Healthineers (Varian)
- Jiangsu Hengrui Medicine
- Kaneka
- Meril Life Sciences
- Peijia Medical
- Wallaby Medical
- MicroPort Scientific Corporation
- Weihai Visee Medical Devices
- Beijing Taijieweiye Technology
1. How big is the global Blood Vessels Embolic Agents market?
2. What is the demand of the global Blood Vessels Embolic Agents market?
3. What is the year over year growth of the global Blood Vessels Embolic Agents market?
4. What is the total value of the global Blood Vessels Embolic Agents market?
5. Who are the major players in the global Blood Vessels Embolic Agents market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Blood Vessels Embolic Agents Introduction
1.2 World Blood Vessels Embolic Agents Market Size & Forecast (2017 & 2021 & 2028)
1.3 World Blood Vessels Embolic Agents Total Market by Region
1.3.1 World Blood Vessels Embolic Agents Market Size by Region (2017-2028)
1.3.2 United States Blood Vessels Embolic Agents Market Size (2017-2028)
1.3.3 China Blood Vessels Embolic Agents Market Size (2017-2028)
1.3.4 Europe Blood Vessels Embolic Agents Market Size (2017-2028)
1.3.5 Japan Blood Vessels Embolic Agents Market Size (2017-2028)
1.3.6 South Korea Blood Vessels Embolic Agents Market Size (2017-2028)
1.3.7 ASEAN Blood Vessels Embolic Agents Market Size (2017-2028)
1.3.8 India Blood Vessels Embolic Agents Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Blood Vessels Embolic Agents Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Blood Vessels Embolic Agents Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 WORLD BLOOD VESSELS EMBOLIC AGENTS COMPANIES COMPETITIVE ANALYSIS
2.1 World Blood Vessels Embolic Agents Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
2.2.1 Global Blood Vessels Embolic Agents Industry Rank of Major Players
2.2.2 Global Concentration Ratios (CR4) for Blood Vessels Embolic Agents in 2021
2.2.3 Global Concentration Ratios (CR8) for Blood Vessels Embolic Agents in 2021
2.3 Blood Vessels Embolic Agents Company Evaluation Quadrant
2.4 Blood Vessels Embolic Agents Market: Overall Company Footprint Analysis
2.4.1 Blood Vessels Embolic Agents Market: Region Footprint
2.4.2 Blood Vessels Embolic Agents Market: Company Product Type Footprint
2.4.3 Blood Vessels Embolic Agents Market: Company Product Application Footprint
2.5 Competitive Environment
2.5.1 Historical Structure of the Industry
2.5.2 Barriers of Market Entry
2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity
3 UNITED STATES VS CHINA VS REST OF THE WORLD
3.1 United States VS China: Blood Vessels Embolic Agents Market Comparison
3.1.1 United States VS China: Blood Vessels Embolic Agents Market Size Comparison (2017 & 2021 & 2028)
3.1.2 United States VS China: Blood Vessels Embolic Agents Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States Blood Vessels Embolic Agents Major Players and Market Share, 2017-2022
3.2.1 Major Players of Blood Vessels Embolic Agents in United States, Headquarters (States, Country)
3.2.2 United States Blood Vessels Embolic Agents Revenue by Domestic Player, (2017-2022)
3.3 China Blood Vessels Embolic Agents Major Players and Market Share, 2017-2022
3.3.1 Major Players of Blood Vessels Embolic Agents in China, Headquarters (Province, Country)
3.3.2 China Blood Vessels Embolic Agents Revenue by Domestic Player, (2017-2022)
3.4 Rest of World Blood Vessels Embolic Agents Major Players and Market Share, 2017-2022
3.4.1 Major Players of Blood Vessels Embolic Agents in Rest of World, Headquarters (State, Country)
3.4.2 Rest of World Blood Vessels Embolic Agents Revenue by Domestic Player, (2017-2022)
4 MARKET ANALYSIS BY TYPE
4.1 World Blood Vessels Embolic Agents Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
4.2.1 Microsphere
4.2.2 Liquid Embolics Agents
4.2.3 Embolic Coils
4.2.4 Embolic Plug Systems
4.2.5 Detachable Balloons
4.2.6 Others
4.3 Market Segment by Type
4.3.1 World Blood Vessels Embolic Agents Market Size by Type (2017-2022)
4.3.2 World Blood Vessels Embolic Agents Market Size by Type (2023-2028)
4.3.3 World Blood Vessels Embolic Agents Market Size Market Share by Type (2017-2028)
5 MARKET ANALYSIS BY APPLICATION
5.1 World Blood Vessels Embolic Agents Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
5.2.1 Hospital & Clinic
5.2.2 Ambulatory Surgical Center
5.2.3 Others
5.3 Market Segment by Application
5.3.1 World Blood Vessels Embolic Agents Market Size by Application (2017-2022)
5.3.2 World Blood Vessels Embolic Agents Market Size by Application (2023-2028)
5.3.3 World Blood Vessels Embolic Agents Market Size by Application (2017-2028)
6 COMPANY PROFILES
6.1 Abbott
6.1.1 Abbott Details
6.1.2 Abbott Major Business
6.1.3 Abbott Blood Vessels Embolic Agents Product and Services
6.1.4 Abbott Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022)
6.1.5 Abbott Recent Developments/Updates
6.1.6 Abbott Competitive Strengths & Weaknesses
6.2 Boston Scientific Corporation
6.2.1 Boston Scientific Corporation Details
6.2.2 Boston Scientific Corporation Major Business
6.2.3 Boston Scientific Corporation Blood Vessels Embolic Agents Product and Services
6.2.4 Boston Scientific Corporation Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022)
6.2.5 Boston Scientific Corporation Recent Developments/Updates
6.2.6 Boston Scientific Corporation Competitive Strengths & Weaknesses
6.3 Cook Medical LLC
6.3.1 Cook Medical LLC Details
6.3.2 Cook Medical LLC Major Business
6.3.3 Cook Medical LLC Blood Vessels Embolic Agents Product and Services
6.3.4 Cook Medical LLC Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022)
6.3.5 Cook Medical LLC Recent Developments/Updates
6.3.6 Cook Medical LLC Competitive Strengths & Weaknesses
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Details
6.4.2 Johnson & Johnson Major Business
6.4.3 Johnson & Johnson Blood Vessels Embolic Agents Product and Services
6.4.4 Johnson & Johnson Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022)
6.4.5 Johnson & Johnson Recent Developments/Updates
6.4.6 Johnson & Johnson Competitive Strengths & Weaknesses
6.5 Medtronic
6.5.1 Medtronic Details
6.5.2 Medtronic Major Business
6.5.3 Medtronic Blood Vessels Embolic Agents Product and Services
6.5.4 Medtronic Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022)
6.5.5 Medtronic Recent Developments/Updates
6.5.6 Medtronic Competitive Strengths & Weaknesses
6.6 Acandis GmbH
6.6.1 Acandis GmbH Details
6.6.2 Acandis GmbH Major Business
6.6.3 Acandis GmbH Blood Vessels Embolic Agents Product and Services
6.6.4 Acandis GmbH Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022)
6.6.5 Acandis GmbH Recent Developments/Updates
6.6.6 Acandis GmbH Competitive Strengths & Weaknesses
6.7 SSEM Mthembu Medical (Pty) Ltd
6.7.1 SSEM Mthembu Medical (Pty) Ltd Details
6.7.2 SSEM Mthembu Medical (Pty) Ltd Major Business
6.7.3 SSEM Mthembu Medical (Pty) Ltd Blood Vessels Embolic Agents Product and Services
6.7.4 SSEM Mthembu Medical (Pty) Ltd Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022)
6.7.5 SSEM Mthembu Medical (Pty) Ltd Recent Developments/Updates
6.7.6 SSEM Mthembu Medical (Pty) Ltd Competitive Strengths & Weaknesses
6.8 Balt USA LLC
6.8.1 Balt USA LLC Details
6.8.2 Balt USA LLC Major Business
6.8.3 Balt USA LLC Blood Vessels Embolic Agents Product and Services
6.8.4 Balt USA LLC Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022)
6.8.5 Balt USA LLC Recent Developments/Updates
6.8.6 Balt USA LLC Competitive Strengths & Weaknesses
6.9 Stryker
6.9.1 Stryker Details
6.9.2 Stryker Major Business
6.9.3 Stryker Blood Vessels Embolic Agents Product and Services
6.9.4 Stryker Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022)
6.9.5 Stryker Recent Developments/Updates
6.9.6 Stryker Competitive Strengths & Weaknesses
6.10 Guerbet LLC
6.10.1 Guerbet LLC Details
6.10.2 Guerbet LLC Major Business
6.10.3 Guerbet LLC Blood Vessels Embolic Agents Product and Services
6.10.4 Guerbet LLC Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022)
6.10.5 Guerbet LLC Recent Developments/Updates
6.10.6 Guerbet LLC Competitive Strengths & Weaknesses
6.11 Terumo Corporation
6.11.1 Terumo Corporation Details
6.11.2 Terumo Corporation Major Business
6.11.3 Terumo Corporation Blood Vessels Embolic Agents Product and Services
6.11.4 Terumo Corporation Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022)
6.11.5 Terumo Corporation Recent Developments/Updates
6.11.6 Terumo Corporation Competitive Strengths & Weaknesses
6.12 Penumbra
6.12.1 Penumbra Details
6.12.2 Penumbra Major Business
6.12.3 Penumbra Blood Vessels Embolic Agents Product and Services
6.12.4 Penumbra Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022)
6.12.5 Penumbra Recent Developments/Updates
6.12.6 Penumbra Competitive Strengths & Weaknesses
6.13 Grandpharma (Sirtex)
6.13.1 Grandpharma (Sirtex) Details
6.13.2 Grandpharma (Sirtex) Major Business
6.13.3 Grandpharma (Sirtex) Blood Vessels Embolic Agents Product and Services
6.13.4 Grandpharma (Sirtex) Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022)
6.13.5 Grandpharma (Sirtex) Recent Developments/Updates
6.13.6 Grandpharma (Sirtex) Competitive Strengths & Weaknesses
6.14 Merit Medical
6.14.1 Merit Medical Details
6.14.2 Merit Medical Major Business
6.14.3 Merit Medical Blood Vessels Embolic Agents Product and Services
6.14.4 Merit Medical Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022)
6.14.5 Merit Medical Recent Developments/Updates
6.14.6 Merit Medical Competitive Strengths & Weaknesses
6.15 Siemens Healthineers (Varian)
6.15.1 Siemens Healthineers (Varian) Details
6.15.2 Siemens Healthineers (Varian) Major Business
6.15.3 Siemens Healthineers (Varian) Blood Vessels Embolic Agents Product and Services
6.15.4 Siemens Healthineers (Varian) Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022)
6.15.5 Siemens Healthineers (Varian) Recent Developments/Updates
6.15.6 Siemens Healthineers (Varian) Competitive Strengths & Weaknesses
6.16 Jiangsu Hengrui Medicine
6.16.1 Jiangsu Hengrui Medicine Details
6.16.2 Jiangsu Hengrui Medicine Major Business
6.16.3 Jiangsu Hengrui Medicine Blood Vessels Embolic Agents Product and Services
6.16.4 Jiangsu Hengrui Medicine Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022)
6.16.5 Jiangsu Hengrui Medicine Recent Developments/Updates
6.16.6 Jiangsu Hengrui Medicine Competitive Strengths & Weaknesses
6.17 Kaneka
6.17.1 Kaneka Details
6.17.2 Kaneka Major Business
6.17.3 Kaneka Blood Vessels Embolic Agents Product and Services
6.17.4 Kaneka Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022)
6.17.5 Kaneka Recent Developments/Updates
6.17.6 Kaneka Competitive Strengths & Weaknesses
6.18 Meril Life Sciences
6.18.1 Meril Life Sciences Details
6.18.2 Meril Life Sciences Major Business
6.18.3 Meril Life Sciences Blood Vessels Embolic Agents Product and Services
6.18.4 Meril Life Sciences Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022)
6.18.5 Meril Life Sciences Recent Developments/Updates
6.18.6 Meril Life Sciences Competitive Strengths & Weaknesses
6.19 Peijia Medical
6.19.1 Peijia Medical Details
6.19.2 Peijia Medical Major Business
6.19.3 Peijia Medical Blood Vessels Embolic Agents Product and Services
6.19.4 Peijia Medical Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022)
6.19.5 Peijia Medical Recent Developments/Updates
6.19.6 Peijia Medical Competitive Strengths & Weaknesses
6.20 Wallaby Medical
6.20.1 Wallaby Medical Details
6.20.2 Wallaby Medical Major Business
6.20.3 Wallaby Medical Blood Vessels Embolic Agents Product and Services
6.20.4 Wallaby Medical Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022)
6.20.5 Wallaby Medical Recent Developments/Updates
6.20.6 Wallaby Medical Competitive Strengths & Weaknesses
6.21 MicroPort Scientific Corporation
6.21.1 MicroPort Scientific Corporation Details
6.21.2 MicroPort Scientific Corporation Major Business
6.21.3 MicroPort Scientific Corporation Blood Vessels Embolic Agents Product and Services
6.21.4 MicroPort Scientific Corporation Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022)
6.21.5 MicroPort Scientific Corporation Recent Developments/Updates
6.21.6 MicroPort Scientific Corporation Competitive Strengths & Weaknesses
6.22 Weihai Visee Medical Devices
6.22.1 Weihai Visee Medical Devices Details
6.22.2 Weihai Visee Medical Devices Major Business
6.22.3 Weihai Visee Medical Devices Blood Vessels Embolic Agents Product and Services
6.22.4 Weihai Visee Medical Devices Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022)
6.22.5 Weihai Visee Medical Devices Recent Developments/Updates
6.22.6 Weihai Visee Medical Devices Competitive Strengths & Weaknesses
6.23 Beijing Taijieweiye Technology
6.23.1 Beijing Taijieweiye Technology Details
6.23.2 Beijing Taijieweiye Technology Major Business
6.23.3 Beijing Taijieweiye Technology Blood Vessels Embolic Agents Product and Services
6.23.4 Beijing Taijieweiye Technology Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022)
6.23.5 Beijing Taijieweiye Technology Recent Developments/Updates
6.23.6 Beijing Taijieweiye Technology Competitive Strengths & Weaknesses
7 RAW MATERIAL AND INDUSTRY CHAIN
7.1 Raw Material of Blood Vessels Embolic Agents and Key Manufacturers
7.2 Blood Vessels Embolic Agents Manufacturing Costs
7.3 Blood Vessels Embolic Agents Production Process
7.4 Blood Vessels Embolic Agents Industrial Chain
8 DISTRIBUTION CHANNEL ANALYSIS
8.1 Distribution Channel Breakdown for Blood Vessels Embolic Agents Shipments (%): 2017-2028
8.1.1 Direct Channel
8.1.2 Indirect Channel
8.2 Blood Vessels Embolic Agents Typical Distributors
8.3 Blood Vessels Embolic Agents Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Blood Vessels Embolic Agents Introduction
1.2 World Blood Vessels Embolic Agents Market Size & Forecast (2017 & 2021 & 2028)
1.3 World Blood Vessels Embolic Agents Total Market by Region
1.3.1 World Blood Vessels Embolic Agents Market Size by Region (2017-2028)
1.3.2 United States Blood Vessels Embolic Agents Market Size (2017-2028)
1.3.3 China Blood Vessels Embolic Agents Market Size (2017-2028)
1.3.4 Europe Blood Vessels Embolic Agents Market Size (2017-2028)
1.3.5 Japan Blood Vessels Embolic Agents Market Size (2017-2028)
1.3.6 South Korea Blood Vessels Embolic Agents Market Size (2017-2028)
1.3.7 ASEAN Blood Vessels Embolic Agents Market Size (2017-2028)
1.3.8 India Blood Vessels Embolic Agents Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Blood Vessels Embolic Agents Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Blood Vessels Embolic Agents Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 WORLD BLOOD VESSELS EMBOLIC AGENTS COMPANIES COMPETITIVE ANALYSIS
2.1 World Blood Vessels Embolic Agents Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
2.2.1 Global Blood Vessels Embolic Agents Industry Rank of Major Players
2.2.2 Global Concentration Ratios (CR4) for Blood Vessels Embolic Agents in 2021
2.2.3 Global Concentration Ratios (CR8) for Blood Vessels Embolic Agents in 2021
2.3 Blood Vessels Embolic Agents Company Evaluation Quadrant
2.4 Blood Vessels Embolic Agents Market: Overall Company Footprint Analysis
2.4.1 Blood Vessels Embolic Agents Market: Region Footprint
2.4.2 Blood Vessels Embolic Agents Market: Company Product Type Footprint
2.4.3 Blood Vessels Embolic Agents Market: Company Product Application Footprint
2.5 Competitive Environment
2.5.1 Historical Structure of the Industry
2.5.2 Barriers of Market Entry
2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity
3 UNITED STATES VS CHINA VS REST OF THE WORLD
3.1 United States VS China: Blood Vessels Embolic Agents Market Comparison
3.1.1 United States VS China: Blood Vessels Embolic Agents Market Size Comparison (2017 & 2021 & 2028)
3.1.2 United States VS China: Blood Vessels Embolic Agents Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States Blood Vessels Embolic Agents Major Players and Market Share, 2017-2022
3.2.1 Major Players of Blood Vessels Embolic Agents in United States, Headquarters (States, Country)
3.2.2 United States Blood Vessels Embolic Agents Revenue by Domestic Player, (2017-2022)
3.3 China Blood Vessels Embolic Agents Major Players and Market Share, 2017-2022
3.3.1 Major Players of Blood Vessels Embolic Agents in China, Headquarters (Province, Country)
3.3.2 China Blood Vessels Embolic Agents Revenue by Domestic Player, (2017-2022)
3.4 Rest of World Blood Vessels Embolic Agents Major Players and Market Share, 2017-2022
3.4.1 Major Players of Blood Vessels Embolic Agents in Rest of World, Headquarters (State, Country)
3.4.2 Rest of World Blood Vessels Embolic Agents Revenue by Domestic Player, (2017-2022)
4 MARKET ANALYSIS BY TYPE
4.1 World Blood Vessels Embolic Agents Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
4.2.1 Microsphere
4.2.2 Liquid Embolics Agents
4.2.3 Embolic Coils
4.2.4 Embolic Plug Systems
4.2.5 Detachable Balloons
4.2.6 Others
4.3 Market Segment by Type
4.3.1 World Blood Vessels Embolic Agents Market Size by Type (2017-2022)
4.3.2 World Blood Vessels Embolic Agents Market Size by Type (2023-2028)
4.3.3 World Blood Vessels Embolic Agents Market Size Market Share by Type (2017-2028)
5 MARKET ANALYSIS BY APPLICATION
5.1 World Blood Vessels Embolic Agents Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
5.2.1 Hospital & Clinic
5.2.2 Ambulatory Surgical Center
5.2.3 Others
5.3 Market Segment by Application
5.3.1 World Blood Vessels Embolic Agents Market Size by Application (2017-2022)
5.3.2 World Blood Vessels Embolic Agents Market Size by Application (2023-2028)
5.3.3 World Blood Vessels Embolic Agents Market Size by Application (2017-2028)
6 COMPANY PROFILES
6.1 Abbott
6.1.1 Abbott Details
6.1.2 Abbott Major Business
6.1.3 Abbott Blood Vessels Embolic Agents Product and Services
6.1.4 Abbott Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022)
6.1.5 Abbott Recent Developments/Updates
6.1.6 Abbott Competitive Strengths & Weaknesses
6.2 Boston Scientific Corporation
6.2.1 Boston Scientific Corporation Details
6.2.2 Boston Scientific Corporation Major Business
6.2.3 Boston Scientific Corporation Blood Vessels Embolic Agents Product and Services
6.2.4 Boston Scientific Corporation Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022)
6.2.5 Boston Scientific Corporation Recent Developments/Updates
6.2.6 Boston Scientific Corporation Competitive Strengths & Weaknesses
6.3 Cook Medical LLC
6.3.1 Cook Medical LLC Details
6.3.2 Cook Medical LLC Major Business
6.3.3 Cook Medical LLC Blood Vessels Embolic Agents Product and Services
6.3.4 Cook Medical LLC Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022)
6.3.5 Cook Medical LLC Recent Developments/Updates
6.3.6 Cook Medical LLC Competitive Strengths & Weaknesses
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Details
6.4.2 Johnson & Johnson Major Business
6.4.3 Johnson & Johnson Blood Vessels Embolic Agents Product and Services
6.4.4 Johnson & Johnson Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022)
6.4.5 Johnson & Johnson Recent Developments/Updates
6.4.6 Johnson & Johnson Competitive Strengths & Weaknesses
6.5 Medtronic
6.5.1 Medtronic Details
6.5.2 Medtronic Major Business
6.5.3 Medtronic Blood Vessels Embolic Agents Product and Services
6.5.4 Medtronic Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022)
6.5.5 Medtronic Recent Developments/Updates
6.5.6 Medtronic Competitive Strengths & Weaknesses
6.6 Acandis GmbH
6.6.1 Acandis GmbH Details
6.6.2 Acandis GmbH Major Business
6.6.3 Acandis GmbH Blood Vessels Embolic Agents Product and Services
6.6.4 Acandis GmbH Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022)
6.6.5 Acandis GmbH Recent Developments/Updates
6.6.6 Acandis GmbH Competitive Strengths & Weaknesses
6.7 SSEM Mthembu Medical (Pty) Ltd
6.7.1 SSEM Mthembu Medical (Pty) Ltd Details
6.7.2 SSEM Mthembu Medical (Pty) Ltd Major Business
6.7.3 SSEM Mthembu Medical (Pty) Ltd Blood Vessels Embolic Agents Product and Services
6.7.4 SSEM Mthembu Medical (Pty) Ltd Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022)
6.7.5 SSEM Mthembu Medical (Pty) Ltd Recent Developments/Updates
6.7.6 SSEM Mthembu Medical (Pty) Ltd Competitive Strengths & Weaknesses
6.8 Balt USA LLC
6.8.1 Balt USA LLC Details
6.8.2 Balt USA LLC Major Business
6.8.3 Balt USA LLC Blood Vessels Embolic Agents Product and Services
6.8.4 Balt USA LLC Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022)
6.8.5 Balt USA LLC Recent Developments/Updates
6.8.6 Balt USA LLC Competitive Strengths & Weaknesses
6.9 Stryker
6.9.1 Stryker Details
6.9.2 Stryker Major Business
6.9.3 Stryker Blood Vessels Embolic Agents Product and Services
6.9.4 Stryker Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022)
6.9.5 Stryker Recent Developments/Updates
6.9.6 Stryker Competitive Strengths & Weaknesses
6.10 Guerbet LLC
6.10.1 Guerbet LLC Details
6.10.2 Guerbet LLC Major Business
6.10.3 Guerbet LLC Blood Vessels Embolic Agents Product and Services
6.10.4 Guerbet LLC Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022)
6.10.5 Guerbet LLC Recent Developments/Updates
6.10.6 Guerbet LLC Competitive Strengths & Weaknesses
6.11 Terumo Corporation
6.11.1 Terumo Corporation Details
6.11.2 Terumo Corporation Major Business
6.11.3 Terumo Corporation Blood Vessels Embolic Agents Product and Services
6.11.4 Terumo Corporation Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022)
6.11.5 Terumo Corporation Recent Developments/Updates
6.11.6 Terumo Corporation Competitive Strengths & Weaknesses
6.12 Penumbra
6.12.1 Penumbra Details
6.12.2 Penumbra Major Business
6.12.3 Penumbra Blood Vessels Embolic Agents Product and Services
6.12.4 Penumbra Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022)
6.12.5 Penumbra Recent Developments/Updates
6.12.6 Penumbra Competitive Strengths & Weaknesses
6.13 Grandpharma (Sirtex)
6.13.1 Grandpharma (Sirtex) Details
6.13.2 Grandpharma (Sirtex) Major Business
6.13.3 Grandpharma (Sirtex) Blood Vessels Embolic Agents Product and Services
6.13.4 Grandpharma (Sirtex) Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022)
6.13.5 Grandpharma (Sirtex) Recent Developments/Updates
6.13.6 Grandpharma (Sirtex) Competitive Strengths & Weaknesses
6.14 Merit Medical
6.14.1 Merit Medical Details
6.14.2 Merit Medical Major Business
6.14.3 Merit Medical Blood Vessels Embolic Agents Product and Services
6.14.4 Merit Medical Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022)
6.14.5 Merit Medical Recent Developments/Updates
6.14.6 Merit Medical Competitive Strengths & Weaknesses
6.15 Siemens Healthineers (Varian)
6.15.1 Siemens Healthineers (Varian) Details
6.15.2 Siemens Healthineers (Varian) Major Business
6.15.3 Siemens Healthineers (Varian) Blood Vessels Embolic Agents Product and Services
6.15.4 Siemens Healthineers (Varian) Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022)
6.15.5 Siemens Healthineers (Varian) Recent Developments/Updates
6.15.6 Siemens Healthineers (Varian) Competitive Strengths & Weaknesses
6.16 Jiangsu Hengrui Medicine
6.16.1 Jiangsu Hengrui Medicine Details
6.16.2 Jiangsu Hengrui Medicine Major Business
6.16.3 Jiangsu Hengrui Medicine Blood Vessels Embolic Agents Product and Services
6.16.4 Jiangsu Hengrui Medicine Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022)
6.16.5 Jiangsu Hengrui Medicine Recent Developments/Updates
6.16.6 Jiangsu Hengrui Medicine Competitive Strengths & Weaknesses
6.17 Kaneka
6.17.1 Kaneka Details
6.17.2 Kaneka Major Business
6.17.3 Kaneka Blood Vessels Embolic Agents Product and Services
6.17.4 Kaneka Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022)
6.17.5 Kaneka Recent Developments/Updates
6.17.6 Kaneka Competitive Strengths & Weaknesses
6.18 Meril Life Sciences
6.18.1 Meril Life Sciences Details
6.18.2 Meril Life Sciences Major Business
6.18.3 Meril Life Sciences Blood Vessels Embolic Agents Product and Services
6.18.4 Meril Life Sciences Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022)
6.18.5 Meril Life Sciences Recent Developments/Updates
6.18.6 Meril Life Sciences Competitive Strengths & Weaknesses
6.19 Peijia Medical
6.19.1 Peijia Medical Details
6.19.2 Peijia Medical Major Business
6.19.3 Peijia Medical Blood Vessels Embolic Agents Product and Services
6.19.4 Peijia Medical Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022)
6.19.5 Peijia Medical Recent Developments/Updates
6.19.6 Peijia Medical Competitive Strengths & Weaknesses
6.20 Wallaby Medical
6.20.1 Wallaby Medical Details
6.20.2 Wallaby Medical Major Business
6.20.3 Wallaby Medical Blood Vessels Embolic Agents Product and Services
6.20.4 Wallaby Medical Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022)
6.20.5 Wallaby Medical Recent Developments/Updates
6.20.6 Wallaby Medical Competitive Strengths & Weaknesses
6.21 MicroPort Scientific Corporation
6.21.1 MicroPort Scientific Corporation Details
6.21.2 MicroPort Scientific Corporation Major Business
6.21.3 MicroPort Scientific Corporation Blood Vessels Embolic Agents Product and Services
6.21.4 MicroPort Scientific Corporation Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022)
6.21.5 MicroPort Scientific Corporation Recent Developments/Updates
6.21.6 MicroPort Scientific Corporation Competitive Strengths & Weaknesses
6.22 Weihai Visee Medical Devices
6.22.1 Weihai Visee Medical Devices Details
6.22.2 Weihai Visee Medical Devices Major Business
6.22.3 Weihai Visee Medical Devices Blood Vessels Embolic Agents Product and Services
6.22.4 Weihai Visee Medical Devices Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022)
6.22.5 Weihai Visee Medical Devices Recent Developments/Updates
6.22.6 Weihai Visee Medical Devices Competitive Strengths & Weaknesses
6.23 Beijing Taijieweiye Technology
6.23.1 Beijing Taijieweiye Technology Details
6.23.2 Beijing Taijieweiye Technology Major Business
6.23.3 Beijing Taijieweiye Technology Blood Vessels Embolic Agents Product and Services
6.23.4 Beijing Taijieweiye Technology Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022)
6.23.5 Beijing Taijieweiye Technology Recent Developments/Updates
6.23.6 Beijing Taijieweiye Technology Competitive Strengths & Weaknesses
7 RAW MATERIAL AND INDUSTRY CHAIN
7.1 Raw Material of Blood Vessels Embolic Agents and Key Manufacturers
7.2 Blood Vessels Embolic Agents Manufacturing Costs
7.3 Blood Vessels Embolic Agents Production Process
7.4 Blood Vessels Embolic Agents Industrial Chain
8 DISTRIBUTION CHANNEL ANALYSIS
8.1 Distribution Channel Breakdown for Blood Vessels Embolic Agents Shipments (%): 2017-2028
8.1.1 Direct Channel
8.1.2 Indirect Channel
8.2 Blood Vessels Embolic Agents Typical Distributors
8.3 Blood Vessels Embolic Agents Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Blood Vessels Embolic Agents Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Blood Vessels Embolic Agents Market Size by Region (2017-2022) & (USD Million)
Table 3. World Blood Vessels Embolic Agents Market Size by Region (2023-2028) & (USD Million)
Table 4. World Blood Vessels Embolic Agents Market Size Market Share by Region (2017-2022)
Table 5. World Blood Vessels Embolic Agents Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World Blood Vessels Embolic Agents Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key Blood Vessels Embolic Agents Players in 2021
Table 9. World Blood Vessels Embolic Agents Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global Blood Vessels Embolic Agents Company Evaluation Quadrant
Table 11. Head Office of Key Blood Vessels Embolic Agents Player
Table 12. Blood Vessels Embolic Agents Market: Company Product Type Footprint
Table 13. Blood Vessels Embolic Agents Market: Company Product Application Footprint
Table 14. Blood Vessels Embolic Agents Mergers & Acquisitions Activity
Table 15. United States VS China Blood Vessels Embolic Agents Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of Blood Vessels Embolic Agents in United States, Headquarters (States, Country)
Table 17. United States Blood Vessels Embolic Agents Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States Blood Vessels Embolic Agents Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of Blood Vessels Embolic Agents in China, Company Headquarters (Province, Country)
Table 20. China Blood Vessels Embolic Agents Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China Blood Vessels Embolic Agents Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of Blood Vessels Embolic Agents in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World Blood Vessels Embolic Agents Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World Blood Vessels Embolic Agents Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World Blood Vessels Embolic Agents Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World Blood Vessels Embolic Agents Revenue by Type (2017-2022) & (USD Million)
Table 27. World Blood Vessels Embolic Agents Revenue by Type (2023-2028) & (USD Million)
Table 28. World Blood Vessels Embolic Agents Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World Blood Vessels Embolic Agents Revenue by Application (2017-2022) & (USD Million)
Table 30. World Blood Vessels Embolic Agents Revenue by Application (2023-2028) & (USD Million)
Table 31. Abbott Basic Information, Area Served and Competitors
Table 32. Abbott Major Business
Table 33. Abbott Blood Vessels Embolic Agents Product and Services
Table 34. Abbott Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Abbott Recent Developments/Updates
Table 36. Abbott Competitive Strengths & Weaknesses
Table 37. Boston Scientific Corporation Basic Information, Area Served and Competitors
Table 38. Boston Scientific Corporation Major Business
Table 39. Boston Scientific Corporation Blood Vessels Embolic Agents Product and Services
Table 40. Boston Scientific Corporation Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. Boston Scientific Corporation Recent Developments/Updates
Table 42. Boston Scientific Corporation Competitive Strengths & Weaknesses
Table 43. Cook Medical LLC Basic Information, Area Served and Competitors
Table 44. Cook Medical LLC Major Business
Table 45. Cook Medical LLC Blood Vessels Embolic Agents Product and Services
Table 46. Cook Medical LLC Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. Cook Medical LLC Recent Developments/Updates
Table 48. Cook Medical LLC Competitive Strengths & Weaknesses
Table 49. Johnson & Johnson Basic Information, Area Served and Competitors
Table 50. Johnson & Johnson Major Business
Table 51. Johnson & Johnson Blood Vessels Embolic Agents Product and Services
Table 52. Johnson & Johnson Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. Johnson & Johnson Recent Developments/Updates
Table 54. Johnson & Johnson Competitive Strengths & Weaknesses
Table 55. Medtronic Basic Information, Area Served and Competitors
Table 56. Medtronic Major Business
Table 57. Medtronic Blood Vessels Embolic Agents Product and Services
Table 58. Medtronic Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. Medtronic Recent Developments/Updates
Table 60. Medtronic Competitive Strengths & Weaknesses
Table 61. Acandis GmbH Basic Information, Area Served and Competitors
Table 62. Acandis GmbH Major Business
Table 63. Acandis GmbH Blood Vessels Embolic Agents Product and Services
Table 64. Acandis GmbH Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. Acandis GmbH Recent Developments/Updates
Table 66. Acandis GmbH Competitive Strengths & Weaknesses
Table 67. SSEM Mthembu Medical (Pty) Ltd Basic Information, Area Served and Competitors
Table 68. SSEM Mthembu Medical (Pty) Ltd Major Business
Table 69. SSEM Mthembu Medical (Pty) Ltd Blood Vessels Embolic Agents Product and Services
Table 70. SSEM Mthembu Medical (Pty) Ltd Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. SSEM Mthembu Medical (Pty) Ltd Recent Developments/Updates
Table 72. SSEM Mthembu Medical (Pty) Ltd Competitive Strengths & Weaknesses
Table 73. Balt USA LLC Basic Information, Area Served and Competitors
Table 74. Balt USA LLC Major Business
Table 75. Balt USA LLC Blood Vessels Embolic Agents Product and Services
Table 76. Balt USA LLC Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. Balt USA LLC Recent Developments/Updates
Table 78. Balt USA LLC Competitive Strengths & Weaknesses
Table 79. Stryker Basic Information, Area Served and Competitors
Table 80. Stryker Major Business
Table 81. Stryker Blood Vessels Embolic Agents Product and Services
Table 82. Stryker Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 83. Stryker Recent Developments/Updates
Table 84. Stryker Competitive Strengths & Weaknesses
Table 85. Guerbet LLC Basic Information, Area Served and Competitors
Table 86. Guerbet LLC Major Business
Table 87. Guerbet LLC Blood Vessels Embolic Agents Product and Services
Table 88. Guerbet LLC Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 89. Guerbet LLC Recent Developments/Updates
Table 90. Guerbet LLC Competitive Strengths & Weaknesses
Table 91. Terumo Corporation Basic Information, Area Served and Competitors
Table 92. Terumo Corporation Major Business
Table 93. Terumo Corporation Blood Vessels Embolic Agents Product and Services
Table 94. Terumo Corporation Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 95. Terumo Corporation Recent Developments/Updates
Table 96. Terumo Corporation Competitive Strengths & Weaknesses
Table 97. Penumbra Basic Information, Area Served and Competitors
Table 98. Penumbra Major Business
Table 99. Penumbra Blood Vessels Embolic Agents Product and Services
Table 100. Penumbra Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 101. Penumbra Recent Developments/Updates
Table 102. Penumbra Competitive Strengths & Weaknesses
Table 103. Grandpharma (Sirtex) Basic Information, Area Served and Competitors
Table 104. Grandpharma (Sirtex) Major Business
Table 105. Grandpharma (Sirtex) Blood Vessels Embolic Agents Product and Services
Table 106. Grandpharma (Sirtex) Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 107. Grandpharma (Sirtex) Recent Developments/Updates
Table 108. Grandpharma (Sirtex) Competitive Strengths & Weaknesses
Table 109. Merit Medical Basic Information, Area Served and Competitors
Table 110. Merit Medical Major Business
Table 111. Merit Medical Blood Vessels Embolic Agents Product and Services
Table 112. Merit Medical Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 113. Merit Medical Recent Developments/Updates
Table 114. Merit Medical Competitive Strengths & Weaknesses
Table 115. Siemens Healthineers (Varian) Basic Information, Area Served and Competitors
Table 116. Siemens Healthineers (Varian) Major Business
Table 117. Siemens Healthineers (Varian) Blood Vessels Embolic Agents Product and Services
Table 118. Siemens Healthineers (Varian) Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 119. Siemens Healthineers (Varian) Recent Developments/Updates
Table 120. Siemens Healthineers (Varian) Competitive Strengths & Weaknesses
Table 121. Jiangsu Hengrui Medicine Basic Information, Area Served and Competitors
Table 122. Jiangsu Hengrui Medicine Major Business
Table 123. Jiangsu Hengrui Medicine Blood Vessels Embolic Agents Product and Services
Table 124. Jiangsu Hengrui Medicine Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 125. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 126. Jiangsu Hengrui Medicine Competitive Strengths & Weaknesses
Table 127. Kaneka Basic Information, Area Served and Competitors
Table 128. Kaneka Major Business
Table 129. Kaneka Blood Vessels Embolic Agents Product and Services
Table 130. Kaneka Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 131. Kaneka Recent Developments/Updates
Table 132. Kaneka Competitive Strengths & Weaknesses
Table 133. Meril Life Sciences Basic Information, Area Served and Competitors
Table 134. Meril Life Sciences Major Business
Table 135. Meril Life Sciences Blood Vessels Embolic Agents Product and Services
Table 136. Meril Life Sciences Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 137. Meril Life Sciences Recent Developments/Updates
Table 138. Meril Life Sciences Competitive Strengths & Weaknesses
Table 139. Peijia Medical Basic Information, Area Served and Competitors
Table 140. Peijia Medical Major Business
Table 141. Peijia Medical Blood Vessels Embolic Agents Product and Services
Table 142. Peijia Medical Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 143. Peijia Medical Recent Developments/Updates
Table 144. Peijia Medical Competitive Strengths & Weaknesses
Table 145. Wallaby Medical Basic Information, Area Served and Competitors
Table 146. Wallaby Medical Major Business
Table 147. Wallaby Medical Blood Vessels Embolic Agents Product and Services
Table 148. Wallaby Medical Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 149. Wallaby Medical Recent Developments/Updates
Table 150. Wallaby Medical Competitive Strengths & Weaknesses
Table 151. MicroPort Scientific Corporation Basic Information, Area Served and Competitors
Table 152. MicroPort Scientific Corporation Major Business
Table 153. MicroPort Scientific Corporation Blood Vessels Embolic Agents Product and Services
Table 154. MicroPort Scientific Corporation Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 155. MicroPort Scientific Corporation Recent Developments/Updates
Table 156. MicroPort Scientific Corporation Competitive Strengths & Weaknesses
Table 157. Weihai Visee Medical Devices Basic Information, Area Served and Competitors
Table 158. Weihai Visee Medical Devices Major Business
Table 159. Weihai Visee Medical Devices Blood Vessels Embolic Agents Product and Services
Table 160. Weihai Visee Medical Devices Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 161. Weihai Visee Medical Devices Recent Developments/Updates
Table 162. Beijing Taijieweiye Technology Basic Information, Area Served and Competitors
Table 163. Beijing Taijieweiye Technology Major Business
Table 164. Beijing Taijieweiye Technology Blood Vessels Embolic Agents Product and Services
Table 165. Beijing Taijieweiye Technology Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 166. Blood Vessels Embolic Agents Raw Material
Table 167. Key Manufacturers of Blood Vessels Embolic Agents Raw Materials
Table 168. Blood Vessels Embolic Agents Typical Distributors
Table 169. Blood Vessels Embolic Agents Typical Customers
Table 1. World Blood Vessels Embolic Agents Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Blood Vessels Embolic Agents Market Size by Region (2017-2022) & (USD Million)
Table 3. World Blood Vessels Embolic Agents Market Size by Region (2023-2028) & (USD Million)
Table 4. World Blood Vessels Embolic Agents Market Size Market Share by Region (2017-2022)
Table 5. World Blood Vessels Embolic Agents Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World Blood Vessels Embolic Agents Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key Blood Vessels Embolic Agents Players in 2021
Table 9. World Blood Vessels Embolic Agents Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global Blood Vessels Embolic Agents Company Evaluation Quadrant
Table 11. Head Office of Key Blood Vessels Embolic Agents Player
Table 12. Blood Vessels Embolic Agents Market: Company Product Type Footprint
Table 13. Blood Vessels Embolic Agents Market: Company Product Application Footprint
Table 14. Blood Vessels Embolic Agents Mergers & Acquisitions Activity
Table 15. United States VS China Blood Vessels Embolic Agents Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of Blood Vessels Embolic Agents in United States, Headquarters (States, Country)
Table 17. United States Blood Vessels Embolic Agents Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States Blood Vessels Embolic Agents Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of Blood Vessels Embolic Agents in China, Company Headquarters (Province, Country)
Table 20. China Blood Vessels Embolic Agents Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China Blood Vessels Embolic Agents Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of Blood Vessels Embolic Agents in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World Blood Vessels Embolic Agents Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World Blood Vessels Embolic Agents Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World Blood Vessels Embolic Agents Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World Blood Vessels Embolic Agents Revenue by Type (2017-2022) & (USD Million)
Table 27. World Blood Vessels Embolic Agents Revenue by Type (2023-2028) & (USD Million)
Table 28. World Blood Vessels Embolic Agents Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World Blood Vessels Embolic Agents Revenue by Application (2017-2022) & (USD Million)
Table 30. World Blood Vessels Embolic Agents Revenue by Application (2023-2028) & (USD Million)
Table 31. Abbott Basic Information, Area Served and Competitors
Table 32. Abbott Major Business
Table 33. Abbott Blood Vessels Embolic Agents Product and Services
Table 34. Abbott Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Abbott Recent Developments/Updates
Table 36. Abbott Competitive Strengths & Weaknesses
Table 37. Boston Scientific Corporation Basic Information, Area Served and Competitors
Table 38. Boston Scientific Corporation Major Business
Table 39. Boston Scientific Corporation Blood Vessels Embolic Agents Product and Services
Table 40. Boston Scientific Corporation Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. Boston Scientific Corporation Recent Developments/Updates
Table 42. Boston Scientific Corporation Competitive Strengths & Weaknesses
Table 43. Cook Medical LLC Basic Information, Area Served and Competitors
Table 44. Cook Medical LLC Major Business
Table 45. Cook Medical LLC Blood Vessels Embolic Agents Product and Services
Table 46. Cook Medical LLC Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. Cook Medical LLC Recent Developments/Updates
Table 48. Cook Medical LLC Competitive Strengths & Weaknesses
Table 49. Johnson & Johnson Basic Information, Area Served and Competitors
Table 50. Johnson & Johnson Major Business
Table 51. Johnson & Johnson Blood Vessels Embolic Agents Product and Services
Table 52. Johnson & Johnson Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. Johnson & Johnson Recent Developments/Updates
Table 54. Johnson & Johnson Competitive Strengths & Weaknesses
Table 55. Medtronic Basic Information, Area Served and Competitors
Table 56. Medtronic Major Business
Table 57. Medtronic Blood Vessels Embolic Agents Product and Services
Table 58. Medtronic Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. Medtronic Recent Developments/Updates
Table 60. Medtronic Competitive Strengths & Weaknesses
Table 61. Acandis GmbH Basic Information, Area Served and Competitors
Table 62. Acandis GmbH Major Business
Table 63. Acandis GmbH Blood Vessels Embolic Agents Product and Services
Table 64. Acandis GmbH Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. Acandis GmbH Recent Developments/Updates
Table 66. Acandis GmbH Competitive Strengths & Weaknesses
Table 67. SSEM Mthembu Medical (Pty) Ltd Basic Information, Area Served and Competitors
Table 68. SSEM Mthembu Medical (Pty) Ltd Major Business
Table 69. SSEM Mthembu Medical (Pty) Ltd Blood Vessels Embolic Agents Product and Services
Table 70. SSEM Mthembu Medical (Pty) Ltd Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. SSEM Mthembu Medical (Pty) Ltd Recent Developments/Updates
Table 72. SSEM Mthembu Medical (Pty) Ltd Competitive Strengths & Weaknesses
Table 73. Balt USA LLC Basic Information, Area Served and Competitors
Table 74. Balt USA LLC Major Business
Table 75. Balt USA LLC Blood Vessels Embolic Agents Product and Services
Table 76. Balt USA LLC Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. Balt USA LLC Recent Developments/Updates
Table 78. Balt USA LLC Competitive Strengths & Weaknesses
Table 79. Stryker Basic Information, Area Served and Competitors
Table 80. Stryker Major Business
Table 81. Stryker Blood Vessels Embolic Agents Product and Services
Table 82. Stryker Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 83. Stryker Recent Developments/Updates
Table 84. Stryker Competitive Strengths & Weaknesses
Table 85. Guerbet LLC Basic Information, Area Served and Competitors
Table 86. Guerbet LLC Major Business
Table 87. Guerbet LLC Blood Vessels Embolic Agents Product and Services
Table 88. Guerbet LLC Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 89. Guerbet LLC Recent Developments/Updates
Table 90. Guerbet LLC Competitive Strengths & Weaknesses
Table 91. Terumo Corporation Basic Information, Area Served and Competitors
Table 92. Terumo Corporation Major Business
Table 93. Terumo Corporation Blood Vessels Embolic Agents Product and Services
Table 94. Terumo Corporation Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 95. Terumo Corporation Recent Developments/Updates
Table 96. Terumo Corporation Competitive Strengths & Weaknesses
Table 97. Penumbra Basic Information, Area Served and Competitors
Table 98. Penumbra Major Business
Table 99. Penumbra Blood Vessels Embolic Agents Product and Services
Table 100. Penumbra Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 101. Penumbra Recent Developments/Updates
Table 102. Penumbra Competitive Strengths & Weaknesses
Table 103. Grandpharma (Sirtex) Basic Information, Area Served and Competitors
Table 104. Grandpharma (Sirtex) Major Business
Table 105. Grandpharma (Sirtex) Blood Vessels Embolic Agents Product and Services
Table 106. Grandpharma (Sirtex) Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 107. Grandpharma (Sirtex) Recent Developments/Updates
Table 108. Grandpharma (Sirtex) Competitive Strengths & Weaknesses
Table 109. Merit Medical Basic Information, Area Served and Competitors
Table 110. Merit Medical Major Business
Table 111. Merit Medical Blood Vessels Embolic Agents Product and Services
Table 112. Merit Medical Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 113. Merit Medical Recent Developments/Updates
Table 114. Merit Medical Competitive Strengths & Weaknesses
Table 115. Siemens Healthineers (Varian) Basic Information, Area Served and Competitors
Table 116. Siemens Healthineers (Varian) Major Business
Table 117. Siemens Healthineers (Varian) Blood Vessels Embolic Agents Product and Services
Table 118. Siemens Healthineers (Varian) Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 119. Siemens Healthineers (Varian) Recent Developments/Updates
Table 120. Siemens Healthineers (Varian) Competitive Strengths & Weaknesses
Table 121. Jiangsu Hengrui Medicine Basic Information, Area Served and Competitors
Table 122. Jiangsu Hengrui Medicine Major Business
Table 123. Jiangsu Hengrui Medicine Blood Vessels Embolic Agents Product and Services
Table 124. Jiangsu Hengrui Medicine Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 125. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 126. Jiangsu Hengrui Medicine Competitive Strengths & Weaknesses
Table 127. Kaneka Basic Information, Area Served and Competitors
Table 128. Kaneka Major Business
Table 129. Kaneka Blood Vessels Embolic Agents Product and Services
Table 130. Kaneka Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 131. Kaneka Recent Developments/Updates
Table 132. Kaneka Competitive Strengths & Weaknesses
Table 133. Meril Life Sciences Basic Information, Area Served and Competitors
Table 134. Meril Life Sciences Major Business
Table 135. Meril Life Sciences Blood Vessels Embolic Agents Product and Services
Table 136. Meril Life Sciences Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 137. Meril Life Sciences Recent Developments/Updates
Table 138. Meril Life Sciences Competitive Strengths & Weaknesses
Table 139. Peijia Medical Basic Information, Area Served and Competitors
Table 140. Peijia Medical Major Business
Table 141. Peijia Medical Blood Vessels Embolic Agents Product and Services
Table 142. Peijia Medical Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 143. Peijia Medical Recent Developments/Updates
Table 144. Peijia Medical Competitive Strengths & Weaknesses
Table 145. Wallaby Medical Basic Information, Area Served and Competitors
Table 146. Wallaby Medical Major Business
Table 147. Wallaby Medical Blood Vessels Embolic Agents Product and Services
Table 148. Wallaby Medical Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 149. Wallaby Medical Recent Developments/Updates
Table 150. Wallaby Medical Competitive Strengths & Weaknesses
Table 151. MicroPort Scientific Corporation Basic Information, Area Served and Competitors
Table 152. MicroPort Scientific Corporation Major Business
Table 153. MicroPort Scientific Corporation Blood Vessels Embolic Agents Product and Services
Table 154. MicroPort Scientific Corporation Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 155. MicroPort Scientific Corporation Recent Developments/Updates
Table 156. MicroPort Scientific Corporation Competitive Strengths & Weaknesses
Table 157. Weihai Visee Medical Devices Basic Information, Area Served and Competitors
Table 158. Weihai Visee Medical Devices Major Business
Table 159. Weihai Visee Medical Devices Blood Vessels Embolic Agents Product and Services
Table 160. Weihai Visee Medical Devices Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 161. Weihai Visee Medical Devices Recent Developments/Updates
Table 162. Beijing Taijieweiye Technology Basic Information, Area Served and Competitors
Table 163. Beijing Taijieweiye Technology Major Business
Table 164. Beijing Taijieweiye Technology Blood Vessels Embolic Agents Product and Services
Table 165. Beijing Taijieweiye Technology Blood Vessels Embolic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 166. Blood Vessels Embolic Agents Raw Material
Table 167. Key Manufacturers of Blood Vessels Embolic Agents Raw Materials
Table 168. Blood Vessels Embolic Agents Typical Distributors
Table 169. Blood Vessels Embolic Agents Typical Customers
LIST OF FIGURES
Figure 1. Blood Vessels Embolic Agents Picture
Figure 2. World Blood Vessels Embolic Agents Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Blood Vessels Embolic Agents Total Market Size (2017-2028) & (USD Million)
Figure 4. World Blood Vessels Embolic Agents Market Size Market Share by Region (2017-2028)
Figure 5. United States Blood Vessels Embolic Agents Market Size (2017-2028) & (USD Million)
Figure 6. China Blood Vessels Embolic Agents Market Size (2017-2028) & (USD Million)
Figure 7. Europe Blood Vessels Embolic Agents Market Size (2017-2028) & (USD Million)
Figure 8. Japan Blood Vessels Embolic Agents Market Size (2017-2028) & (USD Million)
Figure 9. South Korea Blood Vessels Embolic Agents Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN Blood Vessels Embolic Agents Market Size (2017-2028) & (USD Million)
Figure 11. India Blood Vessels Embolic Agents Market Size (2017-2028) & (USD Million)
Figure 12. Blood Vessels Embolic Agents Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of Blood Vessels Embolic Agents by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for Blood Vessels Embolic Agents Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for Blood Vessels Embolic Agents Markets in 2021
Figure 17. United States VS China: Blood Vessels Embolic Agents Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World Blood Vessels Embolic Agents Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World Blood Vessels Embolic Agents Market Size Market Share by Type in 2021
Figure 20. Microsphere
Figure 21. Liquid Embolics Agents
Figure 22. Embolic Coils
Figure 23. Embolic Plug Systems
Figure 24. Detachable Balloons
Figure 25. Others
Figure 26. World Blood Vessels Embolic Agents Market Size Market Share by Type (2017-2028)
Figure 27. World Blood Vessels Embolic Agents Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 28. World Blood Vessels Embolic Agents Market Size Market Share by Application in 2021
Figure 29. Hospital & Clinic
Figure 30. Ambulatory Surgical Center
Figure 31. Others
Figure 32. World Blood Vessels Embolic Agents Market Size Market Share by Application (2017-2028)
Figure 33. Manufacturing Cost Structure Analysis of Blood Vessels Embolic Agents in 2021
Figure 34. Manufacturing Process Analysis of Blood Vessels Embolic Agents
Figure 35. Blood Vessels Embolic Agents Industrial Chain
Figure 36. Distribution Channel Breakdown for Blood Vessels Embolic Agents Shipments (%): 2017-2028
Figure 37. Direct Channel Pros & Cons
Figure 38. Indirect Channel Pros & Cons
Figure 39. Methodology
Figure 40. Research Process and Data Source
Figure 1. Blood Vessels Embolic Agents Picture
Figure 2. World Blood Vessels Embolic Agents Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Blood Vessels Embolic Agents Total Market Size (2017-2028) & (USD Million)
Figure 4. World Blood Vessels Embolic Agents Market Size Market Share by Region (2017-2028)
Figure 5. United States Blood Vessels Embolic Agents Market Size (2017-2028) & (USD Million)
Figure 6. China Blood Vessels Embolic Agents Market Size (2017-2028) & (USD Million)
Figure 7. Europe Blood Vessels Embolic Agents Market Size (2017-2028) & (USD Million)
Figure 8. Japan Blood Vessels Embolic Agents Market Size (2017-2028) & (USD Million)
Figure 9. South Korea Blood Vessels Embolic Agents Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN Blood Vessels Embolic Agents Market Size (2017-2028) & (USD Million)
Figure 11. India Blood Vessels Embolic Agents Market Size (2017-2028) & (USD Million)
Figure 12. Blood Vessels Embolic Agents Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of Blood Vessels Embolic Agents by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for Blood Vessels Embolic Agents Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for Blood Vessels Embolic Agents Markets in 2021
Figure 17. United States VS China: Blood Vessels Embolic Agents Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World Blood Vessels Embolic Agents Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World Blood Vessels Embolic Agents Market Size Market Share by Type in 2021
Figure 20. Microsphere
Figure 21. Liquid Embolics Agents
Figure 22. Embolic Coils
Figure 23. Embolic Plug Systems
Figure 24. Detachable Balloons
Figure 25. Others
Figure 26. World Blood Vessels Embolic Agents Market Size Market Share by Type (2017-2028)
Figure 27. World Blood Vessels Embolic Agents Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 28. World Blood Vessels Embolic Agents Market Size Market Share by Application in 2021
Figure 29. Hospital & Clinic
Figure 30. Ambulatory Surgical Center
Figure 31. Others
Figure 32. World Blood Vessels Embolic Agents Market Size Market Share by Application (2017-2028)
Figure 33. Manufacturing Cost Structure Analysis of Blood Vessels Embolic Agents in 2021
Figure 34. Manufacturing Process Analysis of Blood Vessels Embolic Agents
Figure 35. Blood Vessels Embolic Agents Industrial Chain
Figure 36. Distribution Channel Breakdown for Blood Vessels Embolic Agents Shipments (%): 2017-2028
Figure 37. Direct Channel Pros & Cons
Figure 38. Indirect Channel Pros & Cons
Figure 39. Methodology
Figure 40. Research Process and Data Source
